12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Bial-Portela, Eisai sales and marketing update

Eisai and Bial-Portela launched once-daily oral Zebinix eslicarbazepine in Spain as an adjunct therapy...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >